Halozyme Therapeutics Inc. (HALO)

$ 67.30
   
  • Change Today:
    $0.00
  • 52 Week High: $78.28
  • 52 Week Low: $47.74
  • Currency: US Dollars
  • Shares Issued: 145.30m
  • Volume: 977,260
  • Market Cap: $9,779m
  • RiskGrade: 189

HALO Overview

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

HALO Fundamentals

Fundamentals data is not available for this company.

HALO Forecasts

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-26 1,675.93 1,089.16 813.00¢ 8.3 0.3 +30% n/a 0.0%
31-Dec-27 1,887.98 1,296.54 955.50¢ 7.0 0.4 +18% n/a 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

HALO ShareCast News

Evotec surges on Halozyme takeover interest 15-Nov-2024 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Forecast figures based on normalised accounts.

 

HALO Market Data

Currency US Dollars
Share Price $ 67.30
Change Today $ 0.00
% Change 0.00 %
52 Week High $78.28
52 Week Low $47.74
Volume 977,260
Shares Issued 145.30m
Market Cap $9,779m
RiskGrade 189

What The Brokers Say

Strong Buy 0
Buy 5
Neutral 2
Sell 1
Strong Sell 0
Total 8
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page